Showing results (11-20 of 142) with videos related to
Sort By:
Pageof 15
Biochimica Et Biophysica Acta|May 12, 2000
Two problems in antisense biotechnology: in vitro delivery and the design of antisense experimentsC A SteinCiba Foundation Symposium|January 1, 1997
Controversies in the cellular pharmacology of oligodeoxynucleotidesC A SteinNanotechnology|May 7, 2009
Dissipation and fluctuations in nanoelectromechanical systems based on carbon nanotubesI V Lebedeva, A A Knizhnik, A M Popov, et al.Molekuliarnaia Biologiia|July 1, 1994
[A new method of nonradioactive labelling of oligonucleotides and their use as allele-specific probes for detecting mutations causing beta-thalassemia]I V Lebedeva, M G Ivanovskaia, A N Fedorov, et al.Journal of Bioenergetics and Biomembranes|July 26, 2008
Specific VDAC inhibitors: phosphorothioate oligonucleotidesC A Stein, Marco ColombiniAnnual Review of Pharmacology and Toxicology|March 27, 2001
Antisense oligonucleotides: promise and realityI Lebedeva, C A SteinEuropean Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 26, 2002
Potential roles of antisense oligonucleotides in cancer therapy. The example of Bcl-2 antisense oligonucleotidesNathalie Dias, C A SteinClinical Prostate Cancer|March 30, 2004
Antisense therapy: recent advances and relevance to prostate cancerLuba Benimetskaya, C A SteinDalton Transactions (Cambridge, England : 2003)|April 4, 2014
Formation of nickel-carbon heterofullerenes under electron irradiationA S Sinitsa, I V Lebedeva, A A Knizhnik, et al.Pageof 15